Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Halozyme Therapeutics
HALO
5
Ermenegildo Zegna NV
ZGN
US Stock MarketDetailed Quotes
NIVF NewGenIvf
- 0.2901
- -0.0219-7.02%
Trading Apr 30 14:17 ET
2.60MMarket Cap-5.00P/E (TTM)
0.3270High0.2901Low204.13KVolume0.3150Open0.3120Pre Close62.24KTurnover4.11%Turnover RatioLossP/E (Static)8.97MShares65.600052wk High-2.48P/B1.44MFloat Cap0.261152wk Low--Dividend TTM4.97MShs Float344.8000Historical High--Div YieldTTM11.83%Amplitude0.2610Historical Low0.3040Avg Price1Lot Size
NewGenIvf Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Current assets | |||||||
| Cash, cash equivalents and short term investments | 746.04%457.74K | 96.34%54.1K | 96.34%54.1K | --77.29K | -4.20%27.56K | --27.56K | --28.76K |
| -Cash and cash equivalents | 746.04%457.74K | 96.34%54.1K | 96.34%54.1K | --77.29K | -4.20%27.56K | --27.56K | --28.76K |
| Receivables | 354.73%2.36M | -77.65%519.56K | -77.65%519.56K | --898.3K | 209.74%2.32M | --2.32M | --750.35K |
| -Accounts receivable | 425.34%49.25K | -27.89%9.37K | -27.89%9.37K | --91.89K | -90.90%13K | --13K | --142.92K |
| -Loans receivable | --0 | --140K | --140K | --140K | --0 | --0 | ---- |
| -Related party accounts receivable | --0 | -84.19%354.29K | -84.19%354.29K | --598.79K | 307.42%2.24M | --2.24M | --550.01K |
| -Other receivables | 14,440.09%2.31M | -77.36%15.91K | -77.36%15.91K | --67.62K | 22.41%70.29K | --70.29K | --57.42K |
| -Recievables adjustments allowances | 71.43%-4 | ---14 | ---14 | ---- | ---- | ---- | ---- |
| Inventory | -36.00%80.81K | 169.16%126.26K | 169.16%126.26K | --68.05K | 13.66%46.91K | --46.91K | --41.27K |
| Prepaid assets | -80.39%271.62K | --1.39M | --1.39M | ---- | ---- | ---- | ---- |
| Current deferred assets | --0 | --373.68K | --373.68K | ---- | ---- | ---- | ---- |
| Total current assets | 29.03%3.17M | 2.51%2.46M | 2.51%2.46M | --1.04M | 192.38%2.4M | --2.4M | --820.39K |
| Non current assets | |||||||
| Net PPE | -16.67%371.67K | -11.92%446K | -11.92%446K | --406K | -14.52%506.34K | --506.34K | --592.38K |
| -Gross PPE | -8.74%1.61M | -1.04%1.77M | -1.04%1.77M | --1.68M | -31.39%1.78M | --1.78M | --2.6M |
| -Accumulated depreciation | 6.06%-1.24M | -3.27%-1.32M | -3.27%-1.32M | ---1.28M | 36.36%-1.28M | ---1.28M | ---2.01M |
| Related parties assets | --0 | -84.19%354.29K | -84.19%354.29K | --598.79K | 307.42%2.24M | --2.24M | --550.01K |
| Non current prepaid assets | -97.89%33.33K | --1.58M | --1.58M | ---- | ---- | ---- | ---- |
| Total non current assets | -80.03%405K | 300.55%2.03M | 300.55%2.03M | --406K | -14.52%506.34K | --506.34K | --592.38K |
| Total assets | -20.26%3.58M | 54.46%4.49M | 54.46%4.49M | --1.45M | 105.62%2.9M | --2.9M | --1.41M |
| Liabilities | |||||||
| Current liabilities | |||||||
| Payables | 105.07%1.76M | -11.59%857.31K | -11.59%857.31K | --934.82K | 76.63%969.73K | --969.73K | --549.03K |
| -accounts payable | 652.47%1.3M | 64.95%172.63K | 64.95%172.63K | --152.32K | 123.01%104.65K | --104.65K | --46.93K |
| -Total tax payable | -96.74%16.11K | -13.67%494.06K | -13.67%494.06K | --652.71K | 94.35%572.29K | --572.29K | --294.46K |
| -Due to related parties current | --154.45K | --0 | --0 | --0 | -27.27%110.77K | --110.77K | --152.32K |
| -Other payable | 51.37%288.56K | 4.74%190.63K | 4.74%190.63K | --129.79K | 229.00%182.01K | --182.01K | --55.32K |
| Current accrued expenses | 361.70%201.46K | 95.27%43.63K | 95.27%43.63K | --100.4K | -44.86%22.35K | --22.35K | --40.52K |
| Current debt and capital lease obligation | 223.53%690.97K | 5.00%213.57K | 5.00%213.57K | --196.04K | -69.37%203.41K | --203.41K | --664.15K |
| -Current debt | --582.45K | ---- | ---- | ---- | ---- | ---- | --512.82K |
| -Current capital lease obligation | -49.19%108.53K | 5.00%213.57K | 5.00%213.57K | --196.04K | 34.42%203.41K | --203.41K | --151.33K |
| Current deferred liabilities | 779.90%69.84K | -99.42%7.94K | -99.42%7.94K | --109.27K | 67.48%1.36M | --1.36M | --812.16K |
| Current liabilities | 142.36%2.72M | -56.08%1.12M | -56.08%1.12M | --1.34M | 23.71%2.56M | --2.56M | --2.07M |
| Non current liabilities | |||||||
| Long term debt and capital lease obligation | 1,866.02%2.34M | -52.15%118.98K | -52.15%118.98K | --157.02K | -5.04%248.63K | --248.63K | --261.82K |
| -Long term debt | --2.33M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Long term capital lease obligation | -91.40%10.23K | -52.15%118.98K | -52.15%118.98K | --157.02K | -5.04%248.63K | --248.63K | --261.82K |
| Total non current liabilities | 1,866.02%2.34M | -52.15%118.98K | -52.15%118.98K | --157.02K | -5.04%248.63K | --248.63K | --261.82K |
| Total liabilities | 307.55%5.06M | -55.73%1.24M | -55.73%1.24M | --1.5M | 20.48%2.8M | --2.8M | --2.33M |
| Shareholders'equity | |||||||
| Share capital | --0 | --0 | --0 | --6.02K | 7.46%6.02K | --6.02K | --5.6K |
| -common stock | --0 | --0 | --0 | --6.02K | 7.46%6.02K | --6.02K | --5.6K |
| Retained earnings | -113.72%-985.99K | 22.01%-461.35K | 22.01%-461.35K | ---899.44K | 43.67%-591.54K | ---591.54K | ---1.05M |
| Paid-in capital | -97.17%122.51K | 196.92%4.33M | 196.92%4.33M | --1.46M | 465.87%1.46M | --1.46M | --257.82K |
| Gains losses not affecting retained earnings | 358.99%18.88K | -176.15%-7.29K | -176.15%-7.29K | --37.79K | -11.81%9.57K | --9.57K | --10.85K |
| Other equity interest | -59.92%-204K | 60.12%-127.56K | 60.12%-127.56K | ---127.56K | ---319.87K | ---319.87K | ---- |
| Total stockholders'equity | -128.07%-1.05M | 563.39%3.74M | 563.39%3.74M | --475.74K | 172.57%563.11K | --563.11K | ---775.94K |
| Noncontrolling interests | 11.61%-433.14K | -5.97%-490.05K | -5.97%-490.05K | ---523.64K | -232.75%-462.43K | ---462.43K | ---138.97K |
| Total equity | -145.65%-1.48M | 3,123.54%3.25M | 3,123.54%3.25M | ---47.9K | 111.00%100.68K | --100.68K | ---914.91K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
